New proposed rule continues cuts to Medicare reimbursement; legislative remedies needed to protect patients’ access to care

July 14, 2023
Insurance
The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Chair of the ASTRO Board of Directors, in response to the proposed 2024 Medicare Physician Fee Schedule (MPFS) released today by the Centers for Medicare and Medicaid Services (CMS):

“Another year brings another round of cuts to radiation therapy services for people with cancer under the proposed Medicare fee schedule. ASTRO is disappointed that CMS once again undervalues the impact of radiation oncology and intends to cut reimbursement by an additional 2% in 2024 for this essential cornerstone of cancer care.

Medicare spends less on all radiation therapy services than it does on just three top cancer drugs, although radiation is utilized by twice as many beneficiaries. Despite this outsized value, CMS has cut radiation oncology physician fee schedule payments by over 20% in the last decade – more than nearly all other physician specialties.

The ongoing cuts to radiation oncology reimbursement, coupled with broader cuts to Medicare services, threaten to decrease patients' ability to receive vital, high-value cancer care close to home by driving practice consolidation and undermining the viability of smaller practices. These cuts also underscore the need for long-term, overarching reimbursement reform that will ensure patients can access the care they need.

ASTRO, the leading medical society for radiation oncology with 10,000 members who are physicians, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapy, recently introduced Radiation Oncology Case Rates (ROCR), a legislative proposal for radiation oncology payment reform. We look forward to working with our Congressional champions to pass the bipartisan Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) to mitigate the impact of clinical labor cuts. In addition, we need to advance ROCR to increase patient access to care, improve the quality of cancer treatments, reduce disparities for rural and underserved patients, and lower Medicare and patient costs.”


ABOUT ASTRO
The American Society for Radiation Oncology (ASTRO) is the largest radiation oncology society in the world, with nearly 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.

Back to HCB News

You Must Be Logged In To Post A Comment

 

Insurance Homepage

Cigna and Humana contemplating $60 billion merger, says source
Would face antitrust concerns over pharmacy drug benefit management combination
Cigna rumored to be in talks to sell Medicare Advantage business
Divestment could result in billions of dollars for sale
Blue Cross NC to acquire all 55 North Carolina FastMed urgent care clinics
Will return services to pre-pandemic levels
Four key elements for achieving AI’s true potential for claim payment integrity
Insights from Matthew Hawley, executive vice president of payment integrity for Cotiviti
Mobile cardiac PET provider and founder pay $85 million to settle kickback allegations
Paid referring cardiologists to exclusively send patients their way
Secret shopper investigation reveals differences in hospital price transparency over the phone and online
No uniform standard for how hospitals should post prices
Budget neutrality has cost radiologists $2.8 billion in Medicare reimbursements since 2005: study
Reimbursement has fallen 31.9% since 2005
Bon Secours says Anthem failed to pay $73 million in claims, suing for $93 million
Claims concern visits at its Virginia hospitals from the last four years
Cigna to do away with prior authorizations for 25% of medical procedures
Eliminates more than 600 codes to reduce administrative bottlenecks
AdventHealth accuses MultiPlan of price-fixing scheme costing providers $19 billion annually
Allegedly enriched insurance providers while underpaying on out-of-network claims